Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON

: Keimbahn-Testung gBRCA1 – unauffällig (Beispiel)

Raw json | Download

{
  "resourceType" : "Observation",
  "id" : "ObsGBRCAMamma",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: Observation ObsGBRCAMamma</b></p><a name=\"en-ObsGBRCAMamma\"> </a><a name=\"en-hcObsGBRCAMamma\"> </a><p><b>status</b>: Final</p><p><b>code</b>: <span title=\"Codes:{http://loinc.org 21639-0}\">BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal</span></p><p><b>subject</b>: <a href=\"Patient-PatientinMamma.html\">Sabine Baumann  Female, DoB: 1977-06-24</a></p><p><b>effective</b>: 2025-09-25</p><p><b>value</b>: <span title=\"Codes:{http://snomed.info/sct 260385009}\">Negative</span></p><p><b>note</b>: </p><blockquote><div><p>gBRCA1/2: keine (wahrscheinlich) pathogene Variante (Klasse 4/5) nachgewiesen.</p>\n</div></blockquote></div>"
  },
  "status" : "final",
  "code" : {
    "coding" : [
      {
        "system" : "http://loinc.org",
        "code" : "21639-0",
        "display" : "BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/PatientinMamma"
  },
  "effectiveDateTime" : "2025-09-25",
  "valueCodeableConcept" : {
    "coding" : [
      {
        "system" : "http://snomed.info/sct",
        "code" : "260385009",
        "display" : "Negative"
      }
    ]
  },
  "note" : [
    {
      "text" : "gBRCA1/2: keine (wahrscheinlich) pathogene Variante (Klasse 4/5) nachgewiesen."
    }
  ]
}